Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.2 USD | +0.56% | -0.96% | +7.46% |
May. 20 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
May. 17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.46% | 2.69B | |
+30.65% | 456B | |
+31.55% | 280B | |
+6.35% | 134B | |
+29.89% | 94.31B | |
+4.83% | 91.48B | |
+58.99% | 60.48B | |
+12.88% | 46.13B | |
+24.63% | 37.31B | |
-0.23% | 35.48B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Transcript : GoodRx Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024